Literature DB >> 12446127

Elevated levels of GluR1 in the midbrain: a trigger for sensitization to drugs of abuse?

William A Carlezon1, Eric J Nestler.   

Abstract

In laboratory animals, repeated administration of drugs of abuse, such as cocaine, morphine or alcohol, causes sensitization (reverse tolerance) to their stimulant and rewarding effects. Neuroadaptations underlying sensitization could be related to those that contribute to addictive behaviors. An increased understanding of the molecular mechanisms of sensitization could lead to improved treatments for addiction. Here, we review evidence that the ability of drugs of abuse to elevate levels of the GluR1 subunit of AMPA glutamate receptors in the ventral tegmental area (VTA) of the midbrain is crucial for the development of sensitization. Even transient increases in GluR1 levels within VTA neurons can trigger complex cascades of other molecular adaptations in these neurons and, within larger neural circuits, can cause enduring changes in the responses of the brain to drugs of abuse. However, there is ongoing debate over whether elevated levels of GluR1 in the VTA are a primary cause, or secondary effect, of the neurobiological underpinnings of sensitization.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12446127     DOI: 10.1016/s0166-2236(02)02289-0

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN: 0166-2236            Impact factor:   13.837


  92 in total

1.  A kinesin signaling complex mediates the ability of GSK-3beta to affect mood-associated behaviors.

Authors:  Jing Du; Yanling Wei; Lidong Liu; Yun Wang; Rushaniya Khairova; Rayah Blumenthal; Tyson Tragon; Joshua G Hunsberger; Rodrigo Machado-Vieira; Wayne Drevets; Yu Tian Wang; Husseini K Manji
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-07       Impact factor: 11.205

2.  Afferent-specific AMPA receptor subunit composition and regulation of synaptic plasticity in midbrain dopamine neurons by abused drugs.

Authors:  Cameron H Good; Carl R Lupica
Journal:  J Neurosci       Date:  2010-06-09       Impact factor: 6.167

Review 3.  Synaptic plasticity in the mesolimbic dopamine system.

Authors:  Mark J Thomas; Robert C Malenka
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2003-04-29       Impact factor: 6.237

4.  Spectral confocal imaging of fluorescently tagged nicotinic receptors in knock-in mice with chronic nicotine administration.

Authors:  Anthony Renda; Raad Nashmi
Journal:  J Vis Exp       Date:  2012-02-10       Impact factor: 1.355

Review 5.  Pharmacotherapeutics directed at deficiencies associated with cocaine dependence: focus on dopamine, norepinephrine and glutamate.

Authors:  Colin N Haile; James J Mahoney; Thomas F Newton; Richard De La Garza
Journal:  Pharmacol Ther       Date:  2012-01-31       Impact factor: 12.310

6.  Episodic withdrawal promotes psychomotor sensitization to morphine.

Authors:  Patrick E Rothwell; Jonathan C Gewirtz; Mark J Thomas
Journal:  Neuropsychopharmacology       Date:  2010-09-01       Impact factor: 7.853

7.  Separate mechanisms for development and performance of compulsive checking in the quinpirole sensitization rat model of obsessive-compulsive disorder (OCD).

Authors:  Mark C Tucci; Anna Dvorkin-Gheva; Renee Sharma; Leena Taji; Paul Cheon; John Peel; Ashley Kirk; Henry Szechtman
Journal:  Psychopharmacology (Berl)       Date:  2014-02-28       Impact factor: 4.530

Review 8.  Neurobiologic processes in drug reward and addiction.

Authors:  Bryon Adinoff
Journal:  Harv Rev Psychiatry       Date:  2004 Nov-Dec       Impact factor: 3.732

Review 9.  Recent advances in the development of treatments for alcohol and cocaine dependence: focus on topiramate and other modulators of GABA or glutamate function.

Authors:  Bankole A Johnson
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

10.  Region-specific changes in the subcellular distribution of AMPA receptor GluR1 subunit in the rat ventral tegmental area after acute or chronic morphine administration.

Authors:  Diane A Lane; Andree A Lessard; June Chan; Eric E O Colago; Yan Zhou; Stefan D Schlussman; Mary Jeanne Kreek; Virginia M Pickel
Journal:  J Neurosci       Date:  2008-09-24       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.